Suchergebnisse - "YO603Y8113"

PubPharm (1.117)

81

HIV-1-RNA and total HIV-1-DNA loads in the genital compartment in men receiving dolutegravir- versus darunavir-based combined ART (cART) regimens during primary HIV infection

enthalten in: The Journal of antimicrobial chemotherapy | 2022

von Mariaggi, A. | Bauer, R. | Charre, C. | +10

82

Switching from a Non-Protease inhibitor-Based Regimen To the Fixed Dose Combination of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in Clinical Practice

enthalten in: Drug design, development and therapy | 2022

von Ranzenigo, M. | Gianotti, N. | Galli, L. | +12

ErratumIn: Drug Des Devel Ther. 2022 Oct 27;16:3737-3738. - PMID 36310663

83

Pharmacokinetic Outcomes of the Interactions of Antiretroviral Agents with Food and Supplements : A Systematic Review and Meta-Analysis

enthalten in: Nutrients | 2022

von Siritientong, T. | Thet, D. | Methaneethorn, J. | +1

84

Low Incidence and Brief Duration of Gastrointestinal Adverse Events with Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) Over 96 Weeks : Post hoc Analyses of AMBER and EMERALD

enthalten in: Journal of the International Association of Providers of AIDS Care | 2022

von Dunn, K. | Baugh, B. | Bejou, N. | +4

85

Understanding the co-evolutionary molecular mechanisms of resistance in the HIV-1 Gag and protease

enthalten in: Journal of biomolecular structure & dynamics | 2022

von Marie, V. | Gordon, M.

86

Combinatorial approach of vitamin C derivative and anti-HIV drug-darunavir against SARS-CoV-2

enthalten in: Frontiers in bioscience (Landmark edition) | 2022

von Sahoo, A. | Swain, S. | Paital, B. | +1

87

Darunavir-cobicistat versus lopinavir-ritonavir in the treatment of COVID-19 infection (DOLCI) : A multicenter observational study

enthalten in: PloS one | 2022

von Elmekaty, E. | Alibrahim, R. | Hassanin, R. | +8

88

Switching to a NRTI-free 2 drug regimen (2DR) -a sub-analysis of the 48 weeks DUALIS study on metabolic and renal changes

enthalten in: HIV research & clinical practice | 2021

von Monin, M. | Kümmerle, T. | Schneider, J. | +16

89

Multiple Molecular Dynamics Simulations and Free-Energy Predictions Uncover the Susceptibility of Variants of HIV-1 Protease against Inhibitors Darunavir and KNI-1657

enthalten in: Langmuir : the ACS journal of surfaces and colloids | 2021

von Wang, R. | Zheng, Q.

90

Brief Report : Pharmacokinetics of Bictegravir and Tenofovir in Combination With Darunavir/Cobicistat in Treatment-Experienced Persons With HIV

enthalten in: Journal of acquired immune deficiency syndromes (1999) | 2021

von Salama, E. | Hill, L. | Patel, N. | +2